Comments
Commented by Juliane Zielonka on September 23rd, 2022 | 11:28 CEST
Defence Therapeutics, Amazon, BioNTech - Innovative technologies for health
While WHO Director-General Tedros Adhanom Ghebreyesus sees the end of the Corona pandemic within reach, companies like BioNTech have more products in the pipeline to bring successful drugs to market. In order to ensure that this happens thoroughly and more quickly, Canadian company Defence Therapeutics is stepping up to shorten development cycles with a unique platform technology in oncology. Cancer has still not been eradicated. An end, however, is in sight for Amazon's in-house healthcare division. Amazon Care is closing its doors at the end of the year, but the Seattle-based corporation still cannot let go of the lucrative healthcare business...
Read
Commented by Fabian Lorenz on September 23rd, 2022 | 11:17 CEST
Nel, Steinhoff, Viva Gold: What is going on?
Is the rebound coming for the Nel share, or are all the dams breaking? At the moment, this is the situation with the popular hydrogen specialist. After the quarterly figures, Credit Suisse, among others, lowered their thumbs and the share is also clearly battered on the chart. The latter also applies to Viva Gold. Operationally, things are going well for the Canadians. Can a stabilizing gold price turn investors' attention to the low valuation? Investors have been debating for years whether Steinhoff is favorably valued or not. Recently, the share price jumped significantly. What is going on?
Read
Commented by Stefan Feulner on September 23rd, 2022 | 10:10 CEST
BYD, Kleos Space, Palantir - Market leaders in the clearance sale
In the wake of the major interest rate hike, the US Federal Reserve increased by 75 basis points, and the stock markets again went into a dive. After the statement by Chairman Jerome Powell, the Dow Jones lost more than 1,000 points over the day, and the Nasdaq technology index also ended the day with significant losses. That threatens a further test of the lows for the year. In the course of this, established market leaders from various sectors corrected and now offer attractive long-term entry opportunities at a reduced level.
Read
Commented by André Will-Laudien on September 22nd, 2022 | 14:01 CEST
Uniper and Kion in shock, partial mobilization at BASF and Meta Materials
For the first time in recent history, an announced appearance by Putin did not take place. In the morning yesterday, the news finally rang out that Russia had been so afraid of for the past few weeks: Putin announced partial mobilization. It likely involves an additional 300,000 troops who will now go into mobilization. News about the war apparently only impacts the stock market if it also conceals economic news, because the market rose despite expected escalations. However, the consensus now seems to be that a sharp slowdown in economic growth is expected worldwide. Currently, many stocks are adjusting to a new view: interest rates are back, so capitalization models are recalculating, especially for growth stocks. Where should attention be paid now?
Read
Commented by Nico Popp on September 22nd, 2022 | 13:28 CEST
Here are the rising prices: Nordex, Defense Metals, JinkoSolar
Recession worries and interest rate fears: experience shows that the market always goes up when sentiment is at its lowest. The first market participants, who have so far always been on the side of the bears, see hope. With the upcoming financial season, new bad news could herald the final sell-off. And then? Which stocks have long-term potential, and who could miss out on a special boom?
Read
Commented by Carsten Mainitz on September 22nd, 2022 | 12:47 CEST
Allkem, Infinity Stone, FREYR Battery - Nobody can avoid these stocks!
The current energy crisis makes us painfully aware of how much we have slept through the restructuring of our energy supply in recent decades. The famous scientist Carl Sagan explained in a speech already in 1990, 32 years ago, why a restructuring of the energy supply makes sense completely apart from the effects of the greenhouse effect. Namely, reducing dependence on difficult supplier countries, increasing energy security by extension of fossil resources, and stimulating the economy by creating new industries. Now, finally, we seem to be on the right track. Shareholders can also benefit greatly - if they back the right horses.
Read
Commented by Juliane Zielonka on September 22nd, 2022 | 11:58 CEST
Cardiol Therapeutics, Apple, Nel - Crisis-proof shares, despite inflation
Heart fluttering, pulse racing among investors, share prices highly volatile due to FED measures. Inflation and recessionary times are brutal for investors in the capital market. Three candidates have the potential to become profitable long-term investments: Cardiol Therapeutics, Apple and Nel. Cardiol Therapeutics fills the gap in the pharmaceutical market for the treatment of the heart disease, myocarditis. Apple is increasingly focusing on monitoring heart health, as cardiovascular disease is one of the leading causes of death in industrialized nations. In turn, these nations are struggling with extremely high energy prices. No wonder, then, that the Norwegian government is financially supporting the Company Nel to produce green hydrogen as quickly as possible...
Read
Commented by Stefan Feulner on September 22nd, 2022 | 11:32 CEST
BioNTech, XPhyto, Valneva - It is over!
In an interview with the television station "CBS", the most powerful man in the world, US President Joe Biden, declared the pandemic over. While people in Germany have to wear face masks to the Oktoberfest in local and long-distance transport and then blare the latest hits from Mallorca in the marquee, without masks, of course, outside the former growth engine of Europe, relaxation seems to be setting in regarding COVID-19. A blow to the global vaccine industry! Meanwhile, a new market is growing unnoticed in the healthcare industry that could trigger a lasting trend in the near future.
Read
Commented by Carsten Mainitz on September 22nd, 2022 | 10:25 CEST
Moderna, BrainChip Holdings, Infineon - And the winner is?
For many years now, the Boston Consulting Group (BCG) has been selecting the 50 most innovative companies in the world. A few days ago, the hit list was published for the sixteenth time. The top ranks are occupied by Apple, Microsoft, Amazon, Alphabet and Tesla. German companies are only found with Siemens from rank 20. Innovations play an important role for investors because they enable competitive advantages, which sooner or later translates into rising share prices. But global companies are not always the only ones to be considered; it is often lucrative to look at the second tier.
Read
Commented by Stefan Feulner on September 21st, 2022 | 13:41 CEST
Rock Tech Lithium, Edison Lithium, Albemarle, Allkem - Defying the recession
Fears of a global recession continue to grow, with prices for commodities such as copper, lumber, cotton and even grains correcting sharply. In contrast, the lithium price continues to hold at a high level after the explosive rise at the beginning of the year. The reason for this is the continued strong demand from the electric car industry. In China alone, sales of electric cars amounted to 3.2 million units last year, and 5 million vehicles are expected to be delivered this year. In contrast, the existing supply of lithium resources is scarce. In addition to existing producers, the primary beneficiaries of this shortage are the exploration companies, which have already been able to secure attractive properties.
Read